The University of Chicago Header Logo

Connection

Gladell P. Paner to Male

This is a "connection" page, showing publications Gladell P. Paner has written about Male.
Connection Strength

1.161
  1. Point-Counterpoint: Grade Group 1 (Gleason Score 6) Prostate Cancer Should Be Renamed to Improve Public Health: Pathologists' Perspective. J Urol. 2023 07; 210(1):23-25.
    View in: PubMed
    Score: 0.047
  2. Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration. Hum Pathol. 2022 03; 121:11-18.
    View in: PubMed
    Score: 0.043
  3. Seminal vesicle cystadenoma with dysplasia: missing link to adenocarcinoma? Histopathology. 2021 08; 79(2):274-276.
    View in: PubMed
    Score: 0.041
  4. Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies. Hum Pathol. 2020 12; 106:54-61.
    View in: PubMed
    Score: 0.039
  5. Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer. Cells. 2020 09 17; 9(9).
    View in: PubMed
    Score: 0.039
  6. Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79:82-104: Importance of Standardized Pathology Reporting for Urological Cancers in the Implementation of Urology Guidelines. Eur Urol. 2021 01; 79(1):e30-e32.
    View in: PubMed
    Score: 0.039
  7. Editorial Comment. J Urol. 2020 08; 204(2):265-266.
    View in: PubMed
    Score: 0.038
  8. Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion. Am J Surg Pathol. 2019 04; 43(4):475-479.
    View in: PubMed
    Score: 0.035
  9. Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists. Arch Pathol Lab Med. 2019 05; 143(5):550-564.
    View in: PubMed
    Score: 0.035
  10. Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections. Arch Pathol Lab Med. 2019 12; 143(12):1562-1567.
    View in: PubMed
    Score: 0.035
  11. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum. Virchows Arch. 2018 Jul; 473(1):85-93.
    View in: PubMed
    Score: 0.033
  12. Spectrum of Cystic Epithelial Tumors of the Prostate: Most Cystadenocarcinomas Are Ductal Type With Intracystic Papillary Pattern. Am J Surg Pathol. 2016 07; 40(7):886-95.
    View in: PubMed
    Score: 0.029
  13. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder. Am J Surg Pathol. 2014 Sep; 38(9):1251-9.
    View in: PubMed
    Score: 0.026
  14. Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis. Am J Surg Pathol. 2014 Jan; 38(1):111-8.
    View in: PubMed
    Score: 0.025
  15. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Am J Surg Pathol. 2012 Mar; 36(3):432-42.
    View in: PubMed
    Score: 0.022
  16. Non-epithelial neoplasms of the prostate. Histopathology. 2012 Jan; 60(1):166-86.
    View in: PubMed
    Score: 0.021
  17. Rete testis-associated nodular steroid cell nests: description of putative pluripotential testicular hilus steroid cells. Am J Surg Pathol. 2011 Apr; 35(4):505-11.
    View in: PubMed
    Score: 0.020
  18. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol. 2011 Jan; 18(1):79-89.
    View in: PubMed
    Score: 0.020
  19. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Am J Surg Pathol. 2010 Sep; 34(9):1233-40.
    View in: PubMed
    Score: 0.019
  20. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med. 2008 Sep; 132(9):1388-96.
    View in: PubMed
    Score: 0.017
  21. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol. 2008 Jul; 32(7):1022-8.
    View in: PubMed
    Score: 0.017
  22. High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies. Arch Pathol Lab Med. 2007 Jan; 131(1):81-5.
    View in: PubMed
    Score: 0.015
  23. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol. 2006 Jan; 30(1):13-9.
    View in: PubMed
    Score: 0.014
  24. The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men. Cancer Epidemiol Biomarkers Prev. 2024 Apr 03; 33(4):557-566.
    View in: PubMed
    Score: 0.012
  25. NKX3.1 Expression in Non-Prostatic Tumors and Characterizing its Expression in Esophageal/Gastroesophageal Adenocarcinoma. Adv Anat Pathol. 2024 May 01; 31(3):202-205.
    View in: PubMed
    Score: 0.012
  26. The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. J Natl Cancer Inst. 2023 11 08; 115(11):1364-1373.
    View in: PubMed
    Score: 0.012
  27. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Leuk Lymphoma. 2003 Oct; 44(10):1811-4.
    View in: PubMed
    Score: 0.012
  28. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Anticancer Res. 2003 May-Jun; 23(3B):2253-60.
    View in: PubMed
    Score: 0.012
  29. Physician Perception of Grade Group 1 Prostate Cancer. Eur Urol Focus. 2023 11; 9(6):966-973.
    View in: PubMed
    Score: 0.012
  30. Pathologic quiz case: A cystic mass in the cerebellopontine angle. Arch Pathol Lab Med. 2003 Jan; 127(1):e45-6.
    View in: PubMed
    Score: 0.011
  31. Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue. Urology. 2022 12; 170:154-160.
    View in: PubMed
    Score: 0.011
  32. Low-Grade Prostate Cancer: Time to Stop Calling It Cancer. J Clin Oncol. 2022 09 20; 40(27):3110-3114.
    View in: PubMed
    Score: 0.011
  33. Pathologic quiz case: incidental hepatic nodule on abdominal laparotomy. Arch Pathol Lab Med. 2002 Feb; 126(2):225-6.
    View in: PubMed
    Score: 0.011
  34. Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures. Abdom Radiol (NY). 2022 02; 47(2):801-813.
    View in: PubMed
    Score: 0.011
  35. Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness. J Magn Reson Imaging. 2022 06; 55(6):1745-1758.
    View in: PubMed
    Score: 0.011
  36. Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy. Asian J Androl. 2021 Sep-Oct; 23(5):516-519.
    View in: PubMed
    Score: 0.010
  37. Should Grade Group 1 (GG1) be called cancer? World J Urol. 2022 Jan; 40(1):15-19.
    View in: PubMed
    Score: 0.010
  38. Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists. Adv Anat Pathol. 2021 Jan; 28(1):1-7.
    View in: PubMed
    Score: 0.010
  39. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020 08; 44(8):e87-e99.
    View in: PubMed
    Score: 0.010
  40. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Am J Surg Pathol. 2020 05; 44(5):673-680.
    View in: PubMed
    Score: 0.010
  41. Hepatoid carcinoma of the pancreas. Cancer. 2000 Apr 01; 88(7):1582-9.
    View in: PubMed
    Score: 0.009
  42. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology. 2020 Feb; 52(2):192-196.
    View in: PubMed
    Score: 0.009
  43. [Comparison of UICC and AJCC 8th edition TNM classifications in uropathology]. Ann Pathol. 2019 Apr; 39(2):158-166.
    View in: PubMed
    Score: 0.009
  44. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res. 2018 08 01; 24(15):3668-3680.
    View in: PubMed
    Score: 0.008
  45. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. Am J Surg Pathol. 2018 03; 42(3):279-292.
    View in: PubMed
    Score: 0.008
  46. Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy. Eur Urol Focus. 2019 05; 5(3):416-424.
    View in: PubMed
    Score: 0.008
  47. The New Realization About Cribriform Prostate Cancer. Adv Anat Pathol. 2018 Jan; 25(1):31-37.
    View in: PubMed
    Score: 0.008
  48. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer. Eur Urol Focus. 2019 05; 5(3):433-442.
    View in: PubMed
    Score: 0.008
  49. Lymphoepithelioma-like carcinoma of the upper urinary tract. Virchows Arch. 2017 Jun; 470(6):703-709.
    View in: PubMed
    Score: 0.008
  50. Prostate cancer detection following diagnosis of atypical small acinar proliferation. Can J Urol. 2017 Apr; 24(2):8714-8720.
    View in: PubMed
    Score: 0.008
  51. Influence of pathologist experience on positive surgical margins following radical prostatectomy. Urol Oncol. 2017 07; 35(7):461.e1-461.e6.
    View in: PubMed
    Score: 0.008
  52. Circulating tumor cells capture disease evolution in advanced prostate cancer. J Transl Med. 2017 02 23; 15(1):44.
    View in: PubMed
    Score: 0.008
  53. Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer. Eur Urol. 2017 09; 72(3):455-460.
    View in: PubMed
    Score: 0.008
  54. Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development. Stem Cells Dev. 2016 11 15; 25(22):1733-1741.
    View in: PubMed
    Score: 0.007
  55. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy. Am J Surg Pathol. 2016 10; 40(10):1400-6.
    View in: PubMed
    Score: 0.007
  56. Risk of lymph node metastases in pathological gleason score=6 prostate adenocarcinoma: Analysis of institutional and population-based databases. Urol Oncol. 2017 01; 35(1):31.e1-31.e6.
    View in: PubMed
    Score: 0.007
  57. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
    View in: PubMed
    Score: 0.007
  58. Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations. Am J Surg Pathol. 2015 Oct; 39(10):1331-9.
    View in: PubMed
    Score: 0.007
  59. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World J Urol. 2016 May; 34(5):687-93.
    View in: PubMed
    Score: 0.007
  60. Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists. Am J Surg Pathol. 2015 Sep; 39(9):1242-9.
    View in: PubMed
    Score: 0.007
  61. Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate. Urology. 2015 Oct; 86(4):777-82.
    View in: PubMed
    Score: 0.007
  62. Urinary bladder xanthoma: a multi-institutional series of 17 cases. Histopathology. 2015 Aug; 67(2):255-61.
    View in: PubMed
    Score: 0.007
  63. Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia. Hum Pathol. 2014 Jul; 45(7):1406-13.
    View in: PubMed
    Score: 0.006
  64. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Am J Surg Pathol. 2013 Dec; 37(12):1876-81.
    View in: PubMed
    Score: 0.006
  65. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence. Ann Diagn Pathol. 2014 Apr; 18(2):49-52.
    View in: PubMed
    Score: 0.006
  66. Aire-dependent thymic development of tumor-associated regulatory T cells. Science. 2013 Mar 08; 339(6124):1219-24.
    View in: PubMed
    Score: 0.006
  67. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. PLoS One. 2013; 8(1):e53701.
    View in: PubMed
    Score: 0.006
  68. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. J Urol. 2013 Jan; 189(1):53-8.
    View in: PubMed
    Score: 0.006
  69. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol. 2013 Feb; 44(2):164-72.
    View in: PubMed
    Score: 0.006
  70. Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6. Int J Clin Exp Pathol. 2012; 5(6):496-502.
    View in: PubMed
    Score: 0.006
  71. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression. Clin Cancer Res. 2012 Aug 15; 18(16):4291-302.
    View in: PubMed
    Score: 0.006
  72. Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula. Hum Pathol. 2011 Nov; 42(11):1770-6.
    View in: PubMed
    Score: 0.005
  73. Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells. Clin Cancer Res. 2011 May 15; 17(10):3112-22.
    View in: PubMed
    Score: 0.005
  74. Primary vascular tumors and tumor-like lesions of the kidney: a clinicopathologic analysis of 25 cases. Am J Surg Pathol. 2010 Jul; 34(7):942-9.
    View in: PubMed
    Score: 0.005
  75. Pseudomyxoma peritonei associated with primary mucinous borderline tumor of the renal pelvicalyceal system. Arch Pathol Lab Med. 2009 Sep; 133(9):1472-6.
    View in: PubMed
    Score: 0.005
  76. Comparison of open and robot-assisted pelvic lymphadenectomy for prostate cancer. J Endourol. 2009 Aug; 23(8):1313-7.
    View in: PubMed
    Score: 0.005
  77. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2009 Mar; 33(3):384-92.
    View in: PubMed
    Score: 0.004
  78. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol. 2009 Mar; 33(3):393-400.
    View in: PubMed
    Score: 0.004
  79. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol. 2009 Jan; 33(1):44-9.
    View in: PubMed
    Score: 0.004
  80. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base. Ann Diagn Pathol. 2009 Feb; 13(1):1-8.
    View in: PubMed
    Score: 0.004
  81. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008 Dec; 32(12):1822-34.
    View in: PubMed
    Score: 0.004
  82. Morphometric signature differences in nuclei of Gleason pattern 4 areas in Gleason 7 prostate cancer with differing primary grades on needle biopsy. J Urol. 2009 Jan; 181(1):88-93; discussion 93-4.
    View in: PubMed
    Score: 0.004
  83. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol. 2008 May; 15(3):127-39.
    View in: PubMed
    Score: 0.004
  84. Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases. Virchows Arch. 2008 Jan; 452(1):49-55.
    View in: PubMed
    Score: 0.004
  85. Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer. Prostate. 2007 Oct 01; 67(14):1524-36.
    View in: PubMed
    Score: 0.004
  86. Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning. Virchows Arch. 2006 Sep; 449(3):302-7.
    View in: PubMed
    Score: 0.004
  87. Renal neoplasms in younger adults: analysis of 112 tumors from a single institution according to the new 2004 World Health Organization classification and 2002 American Joint Committee on Cancer Staging System. Arch Pathol Lab Med. 2005 Apr; 129(4):487-91.
    View in: PubMed
    Score: 0.003
  88. Renal tumor with overlapping distal nephron morphology and karyotype. Arch Pathol Lab Med. 2004 Nov; 128(11):1274-8.
    View in: PubMed
    Score: 0.003
  89. Cytogenetic analysis of a series of 13 renal oncocytomas. J Urol. 2004 Feb; 171(2 Pt 1):602-4.
    View in: PubMed
    Score: 0.003
  90. Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances. Urology. 2002 Aug; 60(2):218-22.
    View in: PubMed
    Score: 0.003
  91. A carcinosarcoma/sarcomatoid carcinoma arising in a urinary bladder diverticulum. Arch Pathol Lab Med. 2002 Jul; 126(7):853-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.